Randomization Unethical For VNS Depression Patients, Cyberonics Says
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics says a one-year, 300-patient, non-randomized study should be sufficient to remove placebo effects encountered in its clinical trial evaluating VNS Therapy for depression